NasdaqGS:HSICHealthcare
Is Strong Q3 Results And Raised EPS Guidance Altering The Investment Case For Henry Schein (HSIC)?
Earlier this quarter, Henry Schein reported strong Q3 2025 results, with adjusted EPS and revenue exceeding analyst expectations and management lifting full-year 2025 adjusted EPS guidance alongside projected sales growth.
The guidance upgrade suggests management sees the current mix of higher-margin products and services as supportive of stronger profitability than previously anticipated.
With management now raising full-year guidance, we’ll examine how this confidence reshapes Henry...